Beverly, MA, United States of America

Jon Mabley

This inventor holds 1 USPTO granted patent. Top assignee: Inotek Corporation. Active years: 2001.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jon Mabley: Innovator in Acetaminophen Intoxication Treatment

Introduction

Jon Mabley is a notable inventor based in Beverly, MA (US). He has made significant contributions to the field of medical treatments, particularly in addressing acetaminophen intoxication. His innovative approach has the potential to improve patient outcomes in critical situations.

Latest Patents

Mabley holds a patent for "Compositions and method for treatment of acetaminophen intoxication." This invention provides compositions and methods for treating acetaminophen intoxication using an inhibitor of xanthine oxidase that does not induce superoxide radical formation when introduced into a subject. An example of a xanthine oxidase inhibitor that can be used according to the invention is AHPP. This patent highlights Mabley's commitment to advancing medical science and improving therapeutic options.

Career Highlights

Jon Mabley is associated with Inotek Corporation, where he applies his expertise in developing innovative solutions for medical challenges. His work at Inotek Corporation reflects his dedication to enhancing healthcare through research and development.

Collaborations

Mabley has collaborated with esteemed colleagues, including Andrew L Salzman and Csaba Szabo. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Jon Mabley is a distinguished inventor whose work in the treatment of acetaminophen intoxication showcases his innovative spirit and dedication to improving healthcare. His contributions are invaluable in the ongoing quest for better medical solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…